Abstract:Artesunate (ART) has been reported to have an antifibrotic effect in various organs. The underlying mechanism has not been systematically elucidated. We aimed to clarify the effect of ART on liver fibrosis induced by Schistosoma japonicum ( S . japonicum ) in an experimentally infected rodent model and the potential underlying mechanisms. The effect of ART on hepatic stellate cells (HSCs) was assessed using CCK-8 and Annexin V-FITC/PI staining assays. The experimental model of liver fibrosis was established in the Mongolian gerbil model infected with S . japonicum cercariae and then treated with 20 mg/kg or 40 mg/kg ART. The hydroxyproline (Hyp) content, malondialdehyde (MDA) content, superoxide dismutase (SOD) and glutathione peroxidase (GPX) activities in liver tissue were measured and histopathological changes of liver tissues were observed. Whole-transcriptome RNA sequencing (RNA-seq) of the liver tissues was performed. Differentially expressed genes (DEGs) were identified using bioinformatic analysis and verified by quantitative PCR (qPCR) and western blot assay. ART significantly inhibited the proliferation and induce the apoptosis of HSCs in a dose-dependent manner. In vivo , Hyp content decreased significantly in the ART-H group compared to the model (MOD) group and GPX activity was significantly higher in the ART-H group than in the MOD group. Besides, ART treatment significantly reduced collagen production (p <0.05). A total of 158 DEGs and 44 differentially expressed miRNAs related to ART-induced anti-schistosomiasis liver fibrosis were identified. The qPCR and western blot results of selected DEGs were consistent with the sequencing results. These DEGs were implicated in key pathways such as immune and inflammatory response, integrin-mediated signaling and toll-like receptor signaling pathways. ART is effective against liver fibrosis using Mongolian gerbil model induced by S . japonicum infection. We identified host candidate regulators of schistosomiasis-induced liver fibrosis in response to ART through transcriptomics approach. Artesunate (ART) has been reported to have an antifibrotic effect while the underlying mechanism has not been systematically elucidated. Here, we evaluated the effect of ART on anti-hepatic fibrosis in vitro and in vivo. We found that ART significantly inhibited the proliferation and induced the apoptosis of HSCs. And also ART is effective against liver fibrosis using Mongolian gerbil model induced by Schistosoma japonicum ( S . japonicum ) infection. Hyp content decreased significantly in the ART-H group compared to the MOD group and GPX activity was significantly higher in the ART-H group than in the MOD group. Besides, ART treatment significantly reduced collagen production (p<0.05). A total of 158 DEGs and 44 differentially expressed miRNAs related to ART-induced anti-schistosomiasis liver fibrosis were identified through transcriptomics approach. These DEGs were implicated in key pathways such as immune and inflammatory response, integrin-mediated signaling and toll-like receptor signaling pathways. Our findings suggest that ART is effective against liver fibrosis. Furthermore, we identified 30 host candidate regulators in response to ART, and provides a basis for a better understanding of the molecular mechanisms of ART on anti-hepatic fibrosis.

Effects of Artesunate on Cell Proliferation, Collaging Generating and KLF6 Expression in Hepatic Stellate Cells

Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells

Artesunate Alleviates Schistosomiasis-Induced Liver Fibrosis by Downregulation of Mitochondrial Complex Ⅰ Subunit NDUFB8 and Complex Ⅲ Subunit UQCRC2 in Hepatic Stellate Cells.

Turtle Carapace Decoction and Drug Containing Serum on Hepatic Stellate Cells

Down-regulating Effect of Artesunate on T Lymphocytes ’ Immunosuppression in Human Laryngocarcinoma Cells in Vitro

Dependence of Artesunate on Long Noncoding RNA‐RP11 to Inhibit Epithelial‐mesenchymal Transition of Hepatocellular Carcinoma

Mining host candidate regulators of schistosomiasis-induced liver fibrosis in response to artesunate therapy through transcriptomics approach

[Artesunate Suppresses Cell Proliferation of THP-1 Cells by Inducing Apoptosis].

Luteolin Alleviates Liver Fibrosis in Rat Hepatic Stellate Cell HSC-T6: A Proteomic Analysis

Effects ofAralia on apoptosis and expression of apoptosis-related genes in hepatic stellate cells

Antifibrotic Effects of Luteolin on Hepatic Stellate Cells and Liver Fibrosis by Targeting AKT/mTOR/p70S6K and TGFβ/Smad Signalling Pathways

Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury.

[Effect of anti-fibrosis compound contained serum on procollagen Type I and IV, matrix metalloproteinase and its tissue inhibitor-1 gene expression in HSC-LI90 cell line]

Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis

Effects of AcSDKP on Synthesis and Secretion of Extracellular Matrix in Hepatic Stellate Cells Mediated by TGF-β1

Effects of all-trans retinioc acid on expressions of COL1α2,MMP-2,TIMP-1, and signaling pathway in TGF-β1-simulated rat hepatic stellate cells

Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway

Insight into the therapeutic effects of artesunate in relieving metabolic‐associated steatohepatitis from transcriptomic and lipidomics analyses

The effects of inhibiting the activation of hepatic stellate cells by lignan components from the fruits of Schisandra chinensis and the mechanism of schisanhenol

Effect of interfering RNA targeting high mobility group box chromosomal protein 1 on the biological characters of hepatic stellate cells

Effects of Silibinin on Apoptosis and Α1(i) Collagen Mrna Expression in Human Hepatic Stellate Cells LX-2